2-84870305-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001277053.2(TRABD2A):c.589G>A(p.Glu197Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000173 in 1,613,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000075 ( 0 hom. )
Consequence
TRABD2A
NM_001277053.2 missense
NM_001277053.2 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 4.60
Genes affected
TRABD2A (HGNC:27013): (TraB domain containing 2A) Enables Wnt-protein binding activity and metalloendopeptidase activity. Involved in negative regulation of Wnt signaling pathway and proteolysis. Is integral component of organelle membrane and integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.29020333).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRABD2A | NM_001277053.2 | c.589G>A | p.Glu197Lys | missense_variant | 2/7 | ENST00000409520.7 | NP_001263982.1 | |
TRABD2A | NM_001080824.3 | c.589G>A | p.Glu197Lys | missense_variant | 2/6 | NP_001074293.1 | ||
TRABD2A | NM_001307978.2 | c.589G>A | p.Glu197Lys | missense_variant | 2/5 | NP_001294907.1 | ||
TRABD2A | XM_047443257.1 | c.589G>A | p.Glu197Lys | missense_variant | 2/4 | XP_047299213.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRABD2A | ENST00000409520.7 | c.589G>A | p.Glu197Lys | missense_variant | 2/7 | 1 | NM_001277053.2 | ENSP00000387075.2 | ||
TRABD2A | ENST00000335459.9 | c.589G>A | p.Glu197Lys | missense_variant | 2/6 | 1 | ENSP00000335004.5 | |||
TRABD2A | ENST00000409133.1 | c.589G>A | p.Glu197Lys | missense_variant | 2/5 | 1 | ENSP00000387183.1 | |||
TRABD2A | ENST00000436322.1 | n.*24G>A | downstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152224Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
17
AN:
152224
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249088Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135130
GnomAD3 exomes
AF:
AC:
1
AN:
249088
Hom.:
AF XY:
AC XY:
1
AN XY:
135130
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461710Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727136
GnomAD4 exome
AF:
AC:
11
AN:
1461710
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
727136
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000112 AC: 17AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74380
GnomAD4 genome
AF:
AC:
17
AN:
152224
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 16, 2023 | The c.589G>A (p.E197K) alteration is located in exon 2 (coding exon 2) of the TRABD2A gene. This alteration results from a G to A substitution at nucleotide position 589, causing the glutamic acid (E) at amino acid position 197 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
M;M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Uncertain
D;T;T
Polyphen
D;D;P
Vest4
MutPred
Gain of MoRF binding (P = 0.0142);Gain of MoRF binding (P = 0.0142);Gain of MoRF binding (P = 0.0142);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at